Amy Marsden: Vipoglanstat – A New Treatment for Endometriosis
Amy Marsden, Exam Support Worker at The University of Sheffield, shared a post on LinkedIn:
“Gesynta is developing a new treatment for endometriosis called Vipoglanstat, currently in Phase II of clinical trials. I am really happy to be finding out about this and I wanted to share how it links to my final year research project.
Endometriosis, a gynaecological condition which impacts 1 in 10 menstruators, is currently treated through hormonal-based treatments, painkillers and surgery. These options alleviate symptoms and don’t provide enough relief to most patients.
Last year, I focused my research on a policy proposal (abstract attached) aimed at accelerating the diagnosis of endometriosis through non-invasive tools. By prioritising funding, this approach could help patients access support sooner. However, I was mindful that even with an earlier diagnosis, there lacks an effective drug capable of treating the condition.
This might not be the case for much longer, though. Gesynta has been working on a specific drug that targets Microsomal prostaglandin E synthase (mPGES-1), an enzyme present at high levels in inflamed tissues found in endometriosis lesions. Through the inhibition of mPGES-1, downstream inflammation is reduced.
I am excited to see this work develop.
Link to more information.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Sep 19, 2026, 16:48Complete Fertility Launches New Satellite Clinic in Salisbury
-
Sep 19, 2026, 16:45Lifestyle Choices and Environmental Exposures Can Actually Affect Your DNA – Montgomery Fertility Center
-
Sep 19, 2026, 16:41Natalie Crawford: What’s the Difference Between IUI and IVF?
-
Sep 19, 2026, 16:38Celebrating a Beautiful Family Whose Journey Brought Them 2 Incredible Chapters – Caperton Fertility Institute
-
Sep 19, 2026, 16:29Frozen for 22 Years: Baby Born in Greece From an Embryo Created in 2004
-
Sep 19, 2026, 16:25Barbara Lawrenz: Developmental Competence of Oocytes from Dominant Follicles in the Early Follicular Phase
-
Sep 19, 2026, 16:22Vikram Sinai Talaulikar: The Best Mentors I Could Have Asked For
-
Sep 19, 2026, 15:24Sims IVF Appoints Leading Reproductive Medicine Specialist Prof. Enda McVeigh as New Medical Director
-
Sep 19, 2026, 15:22Early Fee for ESHRE Campus 2026 Ends 30 September